Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,965 public trials 2,022 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

NCT06323525

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Biotherapeutic Department of Chinese PLA General Hospital Beijing, China
  • School of Life Sciences, Peking University Beijing, China
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

NCT06927466

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • Peking University People's Hospital Beijing, China
  • Jiangxi Province pediatric hospital Nanchang, China
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • Children's Hospital of Shanghai Shanghai, China
View Trial Details

Related conditions